Clinical Trials
30
Trial Phases
3 Phases
Drug Approvals
3
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with active mild to moderate ulcerative colitis for the induction of remission.
- Conditions
- Ulcerative colitis
- First Posted Date
- 2024-07-24
- Last Posted Date
- 2025-06-01
- Lead Sponsor
- Faes Farma S.A.
- Target Recruit Count
- 386
- Registration Number
- 2023-509606-30-00
- Locations
- 🇭🇺
Eszak-Budai Szent Janos Centrumkorhaz, Budapest XII, Hungary
🇭🇺Csoeszi Endoszkopos Kft., Kecskemet, Hungary
🇭🇺Heves Varmegyei Markhot Ferenc Oktatokorhaz Es Rendelointezet, Eger, Hungary
Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids
- Conditions
- Haemorrhoids Without Complication
- Interventions
- Drug: PlaceboDrug: Hemorrane plusDrug: Hemorrane
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 21
- Registration Number
- NCT05788497
- Locations
- 🇪🇸
CAP Can Bou, Castelldefels, Barcelona, Spain
🇪🇸CAP Corbera de Llobregat, Corbera de Llobregat, Barcelona, Spain
🇪🇸CAPSBE Les Corts, L'Hospitalet de Llobregat, Barcelona, Spain
Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 59
- Registration Number
- NCT04810390
- Locations
- 🇪🇸
Hospital Universitario de Cruces, Barakaldo, Bizkaia, Spain
🇪🇸Instituto Oftálmologico Quironsalud A Coruña, A Coruña, Spain
🇪🇸Hospital Universitari German Trias i Pujol (HGTiP),, Badalona, Spain
Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency
- Conditions
- Vitamin D DeficiencyVitamin D Insufficiency
- Interventions
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 674
- Registration Number
- NCT04735926
- Locations
- 🇧🇬
MC-1-Sevlievo Ltd., Sevlievo, Bulgaria
🇧🇬Diagnostic & Consultative Center "Sveta Anna" EOOD, Sofia, Bulgaria
🇧🇬Individual Practice Ambulatory for Specialized Medical Care - Cardiology, Obstetrics and Gynecology, Sofia, Bulgaria
A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.
- Conditions
- Allergic Conjunctivitis
- Interventions
- First Posted Date
- 2018-03-27
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Faes Farma, S.A.
- Target Recruit Count
- 228
- Registration Number
- NCT03479307
- Locations
- 🇺🇸
Cornea Consultants of AZ, Phoenix, Arizona, United States
🇺🇸East West Eye Institute, Torrance, California, United States
🇺🇸Andover Eye Associates, Andover, Massachusetts, United States
- Prev
- 1
- 2
- 3
- 4
- Next